Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$177.01 - $223.45 $3.54 Million - $4.47 Million
-20,000 Closed
0 $0
Q1 2021

Apr 29, 2021

BUY
$207.02 - $241.31 $2.07 Million - $2.41 Million
10,000 Added 100.0%
20,000 $4.3 Million
Q4 2020

Feb 08, 2021

BUY
$207.01 - $276.09 $2.07 Million - $2.76 Million
10,000 New
10,000 $2.36 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track American Assets Investment Management, LLC Portfolio

Follow American Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Assets Investment Management, LLC with notifications on news.